1887

Abstract

For a long time infections have been treated using the macrolide antibiotic, clarithromycin. Clarithromycin resistance is increasing worldwide and is the most common cause of treatment failure. Here we review the mechanisms of antibiotic resistance to clarithromycin, detailing the individual and combinations of point mutations found in the 23S rRNA gene associated with resistance. Additionally, we consider the methods used to detect clarithromycin resistance, emphasizing the use of high-throughput next-generation sequencing methods, which were applied to 17 newly sequenced pairs of strains isolated from the antrum and corpus of a recent colonized paediatric population. This set of isolates was composed of six pairs of resistant strains whose phenotype was associated with two point mutations found in the 23S rRNA gene: A2142C and A2143G. Other point mutations were found simultaneously in the same gene, but, according to our results, it is unlikely that they contribute to resistance. Further, among susceptible isolates, genomic variations compatible with mutations previously associated with clarithromycin resistance were detected. Exposure to clarithromycin may select low-frequency variants, resulting in a progressive increase in the resistance rate due to selection pressure.

Funding
This study was supported by the:
  • Jorge M. B. Vítor , New England Biolabs (US) , (Award NA)
  • Filipa F Vale , Fundação para a Ciência e a Tecnologia , (Award PTDC/BTM-SAL/28978/2017)
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000344
2020-03-02
2020-06-04
Loading full text...

Full text loading...

/deliver/fulltext/mgen/6/3/mgen000344.html?itemId=/content/journal/mgen/10.1099/mgen.0.000344&mimeType=html&fmt=ahah

References

  1. Mégraud F, Lehours P, Vale FF. The history of Helicobacter pylori : from phylogeography to paleomicrobiology. Clin Microbiol Infect 2016; 22:922–927 [CrossRef]
    [Google Scholar]
  2. Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pylori . WJG 2014; 20:5594 [CrossRef]
    [Google Scholar]
  3. Mégraud F. Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. Gut Microbes 2013; 4:541–548 [CrossRef]
    [Google Scholar]
  4. Malfertheiner P, Megraud F, O'Morain C, Hungin APS, Jones R et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 consensus report. Aliment Pharmacol Ther 2002; 16:167–180 [CrossRef]
    [Google Scholar]
  5. WHO Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017
  6. Goldman RC, Zakula D, Flamm R, Beyer J, Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994; 38:1496–1500 [CrossRef]
    [Google Scholar]
  7. Robertson MP, Joyce GF. The origins of the RNA world. Cold Spring Harb Perspect Biol 2012; 4:a003608 [CrossRef]
    [Google Scholar]
  8. WSV Y, Vincent NG, Baserga SJ. Ribonucleoproteins in archaeal pre-rRNA processing and modification. Archaea 2013; 2013:614735
    [Google Scholar]
  9. Arenz S, Wilson DN. Bacterial protein synthesis as a target for antibiotic inhibition. Cold Spring Harb Perspect Med 2016; 6:a025361 [CrossRef]
    [Google Scholar]
  10. Vázquez-Laslop N, Mankin AS. How macrolide antibiotics work. Trends Biochem Sci 2018; 43:668–684 [CrossRef]
    [Google Scholar]
  11. Kibwage IO, Hoogmartens J, Roets E, Vanderhaeghe H, Verbist L et al. Antibacterial activities of erythromycins a, B, C, and D and some of their derivatives. Antimicrob Agents Chemother 1985; 28:630–633 [CrossRef]
    [Google Scholar]
  12. Ermolenko DN, Cornish PV, Ha T, Noller HF. Antibiotics that bind to the a site of the large ribosomal subunit can induce mRNA translocation. RNA 2013; 19:158–166 [CrossRef]
    [Google Scholar]
  13. Menninger JR. Functional consequences of binding macrolides to ribosomes. J Antimicrob Chemother 1985; 16 Suppl A:23–34 [CrossRef]
    [Google Scholar]
  14. Vester B, Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 2001; 45:1–12 [CrossRef]
    [Google Scholar]
  15. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori . Helicobacter 1996; 1:227–228 [CrossRef]
    [Google Scholar]
  16. Versalovic J, Shortridge D, Kibler K, Griffy MV, Beyer J et al. Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori . Antimicrob Agents Chemother 1996; 40:477–480 [CrossRef]
    [Google Scholar]
  17. Vianna JS, Ramis IB, Ramos DF, VON Groll A, Silva PEAda. Drug resistance in Helicobacter pylori . Arq Gastroenterol 2016; 53:215–223 [CrossRef]
    [Google Scholar]
  18. Occhialini A, Urdaci M, Doucet-Populaire F, Bébéar CM, Lamouliatte H et al. Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrob Agents Chemother 1997; 41:2724–2728 [CrossRef]
    [Google Scholar]
  19. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997; 41:2621–2628 [CrossRef]
    [Google Scholar]
  20. Versalovic J et al. Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother 1997; 40:283–286 [CrossRef]
    [Google Scholar]
  21. Bukanov NO, Berg DE. Ordered cosmid library and high-resolution physical?genetic map of Helicobacter pylori strain NCTC11638. Mol Microbiol 1994; 11:509–523 [CrossRef]
    [Google Scholar]
  22. Hultén K, Gibreel A, Sköld O, Engstrand L. Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients. Antimicrob Agents Chemother 1997; 41:2550–2553 [CrossRef]
    [Google Scholar]
  23. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53:1374–1384 [CrossRef]
    [Google Scholar]
  24. Wang G, Taylor DE. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 1998; 42:1952–1958 [CrossRef]
    [Google Scholar]
  25. Kocazeybek B, Sakli MK, Yuksel P, Demirci M, Caliskan R et al. Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance. J Med Microbiol 2019; 68:566–573 [CrossRef]
    [Google Scholar]
  26. De Francesco V, Zullo A, Giorgio F, Saracino I, Zaccaro C et al. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy. J Med Microbiol 2014; 63:453–457 [CrossRef]
    [Google Scholar]
  27. Hashemi SJ, Sheikh AF, Goodarzi H, Yadyad MJ, Seyedian SS et al. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect Drug Resist 2019; 12:535–543 [CrossRef]
    [Google Scholar]
  28. Hao Q, Li Y, Zhang Z-J, Liu Y, Gao H. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. WJG 2004; 10:1075–1077 [CrossRef]
    [Google Scholar]
  29. Fontana C, Favaro M, Minelli S, Criscuolo AA, Pietroiusti A et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002; 46:3765–3769 [CrossRef]
    [Google Scholar]
  30. Rimbara E, Noguchi N, Kawai T, Sasatsu M. Novel mutation in 23S rRNA that confers low-level resistance to clarithromycin in Helicobacter pylori . Antimicrob Agents Chemother 2008; 52:3465–3466 [CrossRef]
    [Google Scholar]
  31. Khan R, Nahar S, Sultana J, Ahmad MM, Rahman M. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 2004; 48:3567–3569 [CrossRef]
    [Google Scholar]
  32. Kim KS, Kang JO, Eun CS, Han DS, Choi TY. Mutations in the 23S rRNA gene of Helicobacter pylori associated with clarithromycin resistance. J Korean Med Sci 2002; 17:599–603 [CrossRef]
    [Google Scholar]
  33. Tran VH, Ha TMT, Le PTQ, Phan TN, Tran TNH, TMT H, Le PTQ PTN. Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam. Journal of Global Antimicrobial Resistance 2019; 16:87–91 [CrossRef]
    [Google Scholar]
  34. Zerbetto De Palma G, Mendiondo N, Wonaga A, Viola L, Ibarra D et al. Occurrence of mutations in the antimicrobial target genes related to levofloxacin, clarithromycin, and amoxicillin resistance in Helicobacter pylori Isolates from buenos aires city. Microb Drug Resist 2017; 23:351–358 [CrossRef]
    [Google Scholar]
  35. Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter 2007; 12:505–509 [CrossRef]
    [Google Scholar]
  36. Zhen-Hua Z, De-Qiang H, Yong X, Lin-Lin L, Nong-Hua L. Characterization of 23S rRNA gene mutation in primary and secondary clarithromycin-resistant Helicobacter pylori strains from East China. Turk J Gastroenterol 2009; 24:5–9 [CrossRef]
    [Google Scholar]
  37. Xavier JN, Assumpção MB, da SALdaC. Characterization of 23S rRNA domain V mutations in gastric biopsy patients from the eastern amazon. Mem. Inst. Oswaldo Cruz 2010; 105:314–317 [CrossRef]
    [Google Scholar]
  38. Ribeiro ML, Vitiello L, Miranda MCB, Benvengo YHB, Godoy APO et al. Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. Ann Clin Microbiol Antimicrob 2003; 2:11 [CrossRef]
    [Google Scholar]
  39. Bina JE, Alm RA, Uria-Nickelsen M, Thomas SR, Trust TJ et al. Helicobacter pylori uptake and efflux: basis for intrinsic susceptibility to antibiotics in vitro. Antimicrob Agents Chemother 2000; 44:248–254 [CrossRef]
    [Google Scholar]
  40. Borges-Walmsley MI, Walmsley AR. The structure and function of drug pumps. Trends Microbiol 2001; 9:71–79 [CrossRef]
    [Google Scholar]
  41. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H et al. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli . Mol Microbiol 1995; 16:45–55 [CrossRef]
    [Google Scholar]
  42. Bina JE, Nano F, Hancock REW. Utilization of alkaline phosphatase fusions to identify secreted proteins, including potential efflux proteins and virulence factors from Helicobacter pylori . FEMS Microbiol Lett 1997; 148:63–68 [CrossRef]
    [Google Scholar]
  43. Liu Z-Q, Zheng P-Y, Yang P-C. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. WJG 2008; 14:5217–5222 [CrossRef]
    [Google Scholar]
  44. Alvarez-Ortega C, Olivares J, Martínez JL. Rnd multidrug efflux pumps: what are they good for?. Front Microbiol 2013; 4:7 [CrossRef]
    [Google Scholar]
  45. van Amsterdam K, Bart A, van der Ende A. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob Agents Chemother 2005; 49:1477–1482 [CrossRef]
    [Google Scholar]
  46. Hirata K, Suzuki H, Nishizawa T, Tsugawa H, Muraoka H et al. Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori . J Gastroenterol Hepatol 2010; 25:S75–S79 [CrossRef]
    [Google Scholar]
  47. Iwamoto A, Tanahashi T, Okada R, Yoshida Y, Kikuchi K et al. Whole-genome sequencing of clarithromycin resistant Helicobacter pylori characterizes unidentified variants of multidrug resistant efflux pump genes. Gut Pathog 2014; 6:27 [CrossRef]
    [Google Scholar]
  48. Smiley R, Bailey J, Sethuraman M, Posecion N, Showkat Ali M. Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori . J Microbiol. 2013; 51:612–618 [CrossRef]
    [Google Scholar]
  49. Geng X, Li W, Chen Z, Gao S, Hong W et al. The Bifunctional enzyme spot Is involved in the clarithromycin tolerance of Helicobacter pylori by upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. Antimicrob Agents Chemother 2017; 61: [CrossRef]
    [Google Scholar]
  50. Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ et al. Management of Helicobacter pylori infection-the maastricht v/florence consensus report. Gut 2017; 66:6–30 [CrossRef]
    [Google Scholar]
  51. Glupczynski Y, Broutet N, Cantagrel A, Andersen LP, Alarcon T et al. Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of helicobacter pylori. Eur J Clin Microbiol Infect Dis 2002; 21:549–552 [CrossRef]
    [Google Scholar]
  52. Coudron PE, Stratton CW. Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol 1995; 33:1028–1030 [CrossRef]
    [Google Scholar]
  53. Hachem CY, Clarridge JE, Reddy R, Flamm R, Evans DG et al. Antimicrobial susceptibility testing of Helicobacter pylori comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole. Diagn Microbiol Infect Dis 1996; 24:37–41 [CrossRef]
    [Google Scholar]
  54. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol 1997; 35:1842–1846 [CrossRef]
    [Google Scholar]
  55. Menard A, Santos A, Megraud F, Oleastro M. PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother 2002; 46:1156–1157 [CrossRef]
    [Google Scholar]
  56. Oleastro M, Menard A, Santos A, Lamouliatte H, Monteiro L et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori . J Clin Microbiol 2003; 41:397–402 [CrossRef]
    [Google Scholar]
  57. van Doorn L-J, Debets-Ossenkopp YJ, Marais A, Sanna R, Mégraud F et al. Rapid detection, by PCR and reverse hybridization, of mutations in the Helicobacter pylori 23S rRNA gene, associated with macrolide resistance. Antimicrob Agents Chemother 1999; 43:1779–1782 [CrossRef]
    [Google Scholar]
  58. Cambau E, Allerheiligen V, Coulon C, Corbel C, Lascols C et al. Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori . J Clin Microbiol 2009; 47:3600–3607 [CrossRef]
    [Google Scholar]
  59. Cerqueira L, Fernandes RM, Ferreira RM, Oleastro M, Carneiro F et al. Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol 2013; 51:1887–1893 [CrossRef]
    [Google Scholar]
  60. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. Journal of Computational Biology 2012; 19:455–477 [CrossRef]
    [Google Scholar]
  61. Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C et al. A global overview of the genetic and functional diversity in the Helicobacter pylori CAG pathogenicity island. PLoS Genet 2010; 6:e1001069 [CrossRef]
    [Google Scholar]
  62. Kraft C, Stack A, Josenhans C, Niehus E, Dietrich G et al. Genomic changes during chronic Helicobacter pylori infection. J Bacteriol 2006; 188:249–254 [CrossRef]
    [Google Scholar]
  63. Linz B, Windsor HM, McGraw JJ, Hansen LM, Gajewski JP et al. A mutation burst during the acute phase of Helicobacter pylori infection in humans and rhesus macaques. Nat Commun 2014; 5:4165 [CrossRef]
    [Google Scholar]
  64. Draper JL, Hansen LM, Bernick DL, Abedrabbo S, Underwood JG et al. Fallacy of the unique genome: sequence diversity within single Helicobacter pylori Strains. mBio 2017; 8:e02321-16 [CrossRef]
    [Google Scholar]
  65. Denton JF, Lugo-Martinez J, Tucker AE, Schrider DR, Warren WC et al. Extensive error in the number of genes inferred from draft genome assemblies. PLoS Comput Biol 2014; 10:e1003998 [CrossRef]
    [Google Scholar]
  66. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The sequence alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [CrossRef]
    [Google Scholar]
  67. Kim S, Chen J, Cheng T, Gindulyte A, He J et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res 2019; 47:D1102–D1109 [CrossRef]
    [Google Scholar]
  68. Cannone JJ, Subramanian S, Schnare MN, Collett JR, D'Souza LM et al. The comparative RNA web (CRW) site: an online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics 2002; 3:2 [CrossRef]
    [Google Scholar]
  69. Matta AJ, Zambrano DC, Pazos AJ. Punctual mutations in 23S rRNA gene of clarithromycin-resistant Helicobacter pylori in Colombian populations. WJG 2018; 24:1531–1539 [CrossRef]
    [Google Scholar]
  70. Phan TN, Santona A, Tran VH, Tran TNH, Le VA et al. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam. Int J Antimicrob Agents 2015; 45:244–248 [CrossRef]
    [Google Scholar]
  71. Toracchio S, Aceto GM, Mariani-Costantini R, Battista P, Marzio L. Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori . Helicobacter 2004; 9:396–399 [CrossRef]
    [Google Scholar]
  72. Lauener FN, Imkamp F, Lehours P, Buissonnière A, Benejat L et al. Genetic determinants and prediction of antibiotic resistance phenotypes in Helicobacter pylori . J Clin Med 8:53 [CrossRef]
    [Google Scholar]
  73. van Doorn L-J, Glupczynski Y, Kusters JG, Megraud F, Midolo P et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001; 45:1500–1504 [CrossRef]
    [Google Scholar]
  74. Bińkowska A, Biernat MM, Łaczmański Łukasz, Gościniak G. Molecular patterns of resistance among Helicobacter pylori strains in south-western Poland. Front Microbiol 2018; 9:3154 [CrossRef]
    [Google Scholar]
  75. Kageyama C, Sato M, Sakae H, Obayashi Y, Kawahara Y et al. Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan]]>. Infect Drug Resist 2019; 12:597–602 [CrossRef]
    [Google Scholar]
  76. Agudo S, Perez-Perez G, Alarcon T, Lopez-Brea M. High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain. J Clin Microbiol 2010; 48:3703–3707 [CrossRef]
    [Google Scholar]
  77. Quek C, Pham ST, Tran KT, Pham BT, Huynh LV et al. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Research 2016; 5:671 [CrossRef]
    [Google Scholar]
  78. Kim JM, Kim JS, Kim N, Kim Y-J, Kim IY et al. Gene mutations of 23S rRNA associated with clarithromycin resistance in Helicobacter pylori strains isolated from Korean patients. J Microbiol Biotechnol 2008; 18:1584–1589
    [Google Scholar]
  79. Park C-G, Kim S, Lee E-J, Jeon H-S, Han S. Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication: a prospective, observational study. Medicine 2018; 97:e11835 [CrossRef]
    [Google Scholar]
  80. Khademi F, Faghri J, Moghim S, Esfahani BN, Fazeli H et al. The study of mutation in 23S rRNA resistance gene of Helicobacter pylori to clarithromycin in patients with gastrointestinal disorders in Isfahan - Iran. Adv Biomed Res 2014; 3:98 [CrossRef]
    [Google Scholar]
  81. Stone GG, Shortridge D, Versalovic J, Beyer J, Flamm RK et al. A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori . Antimicrob Agents Chemother 1997; 41:712–714 [CrossRef]
    [Google Scholar]
  82. Pina M, Occhialini A, Monteiro L, Doermann H-P, Mégraud F. Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase. J Clin Microbiol 1998; 36:3285–3290 [CrossRef]
    [Google Scholar]
  83. Marais A, Monteiro L, Occhialini A, Pina M, Lamouliatte H et al. Direct detection of Helicobacter pylori resistance to macrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999; 44:463–467 [CrossRef]
    [Google Scholar]
  84. Maeda S, Yoshida H, Matsunaga H, Ogura K, Kawamata O et al. Detection of clarithromycin-resistant Helicobacter pylori strains by a preferential homoduplex formation assay. J Clin Microbiol 2000; 38:210–214
    [Google Scholar]
  85. Burucoa C, Garnier M, Silvain C, Fauchere J-L. Quadruplex real-time PCR assay using allele-specific scorpion primers for detection of mutations conferring clarithromycin resistance to Helicobacter pylori . J Clin Microbiol 2008; 46:2320–2326 [CrossRef]
    [Google Scholar]
  86. Elviss NC, Lawson AJ, Owen RJ. Application of 3′-mismatched reverse primer PCR compared with real-time PCR and PCR-RFLP for the rapid detection of 23S rDNA mutations associated with clarithromycin resistance in Helicobacter pylori . Int J Antimicrob Agents 2004; 23:349–355 [CrossRef]
    [Google Scholar]
  87. Xing JZ, Clarke C, Zhu L, Gabos S. Development of a microelectronic chip array for high-throughput genotyping of Helicobacter species and screening for antimicrobial resistance. J Biomol Screen 2005; 10:235–245 [CrossRef]
    [Google Scholar]
  88. Woo H-Y, Park DI, Park H, Kim M-K, Kim DH et al. Dual-priming oligonucleotide-based multiplex PCR for the detection of Helicobacter pylori and determination of clarithromycin resistance with gastric biopsy specimens. Helicobacter 2009; 14:22–28 [CrossRef]
    [Google Scholar]
  89. Song Y, Dou F, Zhou Z, Yang N, Zhong J et al. Microarray-based detection and clinical evaluation for Helicobacter pylori resistance to clarithromycin or levofloxacin and the genotype of CYP2C19 in 1083 patients. Biomed Res Int 2018; 2018:2684836 [CrossRef]
    [Google Scholar]
  90. Sun L, Talarico S, Yao L, He L, Self S et al. Droplet digital PCR-based detection of clarithromycin resistance in Helicobacter pylori Isolates reveals frequent heteroresistance. J Clin Microbiol 2018; 56: [CrossRef]
    [Google Scholar]
  91. Jung DH, Kim J-H, Jeong SJ, Park SY, Kang I-M et al. Peptide nucleic acid probe-based analysis as a new detection method for clarithromycin resistance in Helicobacter pylori . Gut Liver 2018; 12:641–647 [CrossRef]
    [Google Scholar]
  92. Nezami BG, Jani M, Alouani D, Rhoads DD, Sadri N. Helicobacter pylori mutations detected by next-generation sequencing in formalin-fixed, paraffin-embedded gastric biopsy specimens are associated with treatment failure. J Clin Microbiol 2019; 57: [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000344
Loading
/content/journal/mgen/10.1099/mgen.0.000344
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error